DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

被引：0
|
作者：
Board, Ruth E. [1 ]
Knight, Lucy [2 ]
Greystoke, Alastair [1 ]
Blackhall, Fiona H. [3 ]
Hughes, Andrew [4 ]
Dive, Caroline [5 ]
Ranson, Malcolm [6 ]
机构：
[1] Paterson Inst Canc Res, Clin & Expt Pharmacol, Wilmslow Rd, Manchester M20 4BX, Lancs, England
[2] AstraZeneca, Discovery Med, Macclesfield SK10 4TG, Cheshire, England
[3] Christie Hosp NHS Trust, CRUK Dept Med Oncol, Manchester M20 4BX, Lancs, England
[4] AstraZeneca, Discovery Med, Macclesfield SK10 4TG, Cheshire, England
[5] Paterson Inst Canc Res, Clin & Expt Pharmacol, Manchester M20 4BX, Lancs, England
[6] Christie Hosp NHS Trust, CRUK Dept Med Oncol, Manchester M20 4BX, Lancs, England
来源：
BIOMARKER INSIGHTS | 2007年 / 2卷
关键词：
DNA methylation; biomarker; circulating tumour DNA; MSP; MethyLight;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Free circulating DNA, which is thought to be derived from the primary tumour, can be detected in the blood of patients with cancer. Detection of genetic and epigenetic alteration in this tumour DNA offers a potential source of development of prognostic and predictive biomarkers for cancer. One such change is DNA methylation of the promotor region of tumour suppressor genes. This causes down regulation of tumour suppressor gene expression, a frequent event in carcinogenesis. Hypermethylation of the promotor region of a number of genes has been detected in many tumour types and more recently these changes have been detected in circulating tumour DNA. This review will summarise the literature detailing DNA methylation in circulating tumour DNA and discuss some of the current controversies and technical challenges facing its use as a potential biomarker for cancer.
引用
收藏
页码：307 / 319
页数：13
相关论文
共 50 条
  • [1] Circulating tumour DNA as a cancer biomarker
    Duffy, Michael J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2019, 56 (01) : 42 - 48
  • [2] DNA methylation in circulating free DNA as a new biomarker for pancreatic cancer
    Shinjo, Keiko
    Ohka, Fumiharu
    Katsushima, Keisuke
    Hatanaka, Akira
    Ichimura, Norihisa
    Juan, Zhao
    Yamao, Kenji
    Kondo, Yutaka
    CANCER RESEARCH, 2015, 75
  • [3] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Naidoo, Mahendra
    Piercey, Oliver
    Tie, Jeanne
    CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
  • [4] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Mahendra Naidoo
    Oliver Piercey
    Jeanne Tie
    Current Oncology Reports, 2021, 23
  • [5] Circulating tumour DNA, a promising biomarker for the management of colorectal cancer
    Khakoo, Shelize
    Georgiou, Alexandros
    Gerlinger, Marco
    Cunningham, David
    Starling, Naureen
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 122 : 72 - 82
  • [6] Circulating tumour DNA as a therapeutic biomarker for radiotherapy
    Bratman, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S59 - S60
  • [7] Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer
    Shavali, Mehrdad
    Moradi, Arash
    Tahmaseb, Mohammad
    Mohammadian, Kamal
    Ganji, Shahla Mohammad
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [8] Potential of circulating tumour DNA as a biomarker in liquid biopsy
    Dimitrov, Dimitar
    Ivanov, Hristo
    Miteva-Marcheva, Nelly
    Stoyanova, Vili
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2023, 37 (01)
  • [9] Assessing Circulating TumOur DNA as a prognostic biomarker in endometrial cancer (The CODEC Study)
    Delahunty, Rachel
    Arnolda, Rainier
    Koh, Thuan Tzen
    Hofman, Michael
    Johnston, Hayley
    Wojtowicz, Patricia
    Nguyen, Caitlyn
    Brooks, Nicole
    Reid, Kym
    Lamont, Julie
    Jobling, Thomas
    Neesham, Deborah
    Obers, Vanessa
    Shadbolt, Clair
    Sawyer, Brooke
    Smith, Paul
    Ellis, Jennifer
    Goss, Geradline
    Volcheck, Mila
    Jayawardana, Madawa
    Silva, Sandun
    Hewitt, Chelsee
    Jones, Kate
    Fellowes, Andrew
    McNally, Orla
    Wong, Stephen
    Christie, Elizabeth
    Yannakou, Costas
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [10] DNA methylation age as a biomarker for cancer
    Lau, Chung-Ho E.
    Robinson, Oliver
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (11) : 2652 - 2663
12345